Litcius/Paper detail

Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

Zhenyu Zhong, Dan Deng, Yu Gao, Qingqing Bu, Lingyu Dai, Xiaojie Feng, Chong Tang, Xiang Luo, Yao Wang, Chunjiang Zhou, Guannan Su, Peizeng Yang

2024The Lancet Rheumatology29 citationsDOI

Topics & Concepts

MedicineAdalimumabUveitisInternal medicineRandomized controlled trialAdverse effectClinical trialBehcet's diseaseInfliximabSurgeryDiseaseImmunologyOcular Diseases and Behçet’s SyndromeAutoimmune and Inflammatory Disorders ResearchOtitis Media and Relapsing Polychondritis
Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial | Litcius